Microglia TRPC1 SUMOylation drives neuroinflammation after stroke by modulating NLRP3 activity via increasing TRPC1 interaction with ARRB2

Microglial canonical transient receptor potential channel 1 (TRPC1) has been proposed to influence neuroinflammation after cerebral ischemia and reperfusion injury (CIRI), however, the underlying mechanism remains poorly understood. This study demonstrates that TRPC1 is modified by small ubiquitin-r...

Full description

Saved in:
Bibliographic Details
Main Authors: Huinan Zhang, Xinzhe Du, Tian Gao, Xing Wang, Huifeng Zhang, Manyang Yu, Jing Huang
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S096999612500049X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861212475031552
author Huinan Zhang
Xinzhe Du
Tian Gao
Xing Wang
Huifeng Zhang
Manyang Yu
Jing Huang
author_facet Huinan Zhang
Xinzhe Du
Tian Gao
Xing Wang
Huifeng Zhang
Manyang Yu
Jing Huang
author_sort Huinan Zhang
collection DOAJ
description Microglial canonical transient receptor potential channel 1 (TRPC1) has been proposed to influence neuroinflammation after cerebral ischemia and reperfusion injury (CIRI), however, the underlying mechanism remains poorly understood. This study demonstrates that TRPC1 is modified by small ubiquitin-related modifier (SUMO)ylation. Our findings suggest a notable increase in microglial TRPC1 SUMOylation within both the middle cerebral artery occlusion reperfusion (MCAO/R) model and the in vitro oxygen-glucose deprivation/regeneration model. Mice with a loss of TRPC1 SUMOylation in microglia exhibited improved stroke outcomes including reduced behavior deficits, infarct volume, blood brain barrier damage as well as neuronal apoptosis. Mechanistically, SUMOylation of microglial TRPC1 exacerbated neutrophil infiltration into the peri-infarct area. Additionally, SUMOylated TRPC1 activates the Nod-like receptor protein (NLRP) 3 signaling pathway in microglia and stimulates multiple CC-chemokine ligands and C-X-C motif ligand chemokines after MCAO/R. SUMOylated TRPC1 facilitates the interaction between TRPC1 and β-arrestin2 (ARRB2), a negative regulator of NLRP3 inflammasome, which disrupts the NLPR3/ARRB2 complex and stimulates the activation of the NLPR3 signaling pathway. Furthermore, ARRB2 directly binds to the residues 46 to 61 of TRPC1 N terminus, which is enhanced by TRPC1 SUMOylation. Collectively, our findings demonstrate a previously unidentified mechanism by which SUMOylated TRPC1 in microglia regulates leukocyte infiltration after stroke, suggesting that the inhibition of microglial TRPC1 SUMOylation may provide therapeutic benefits for CIRI.
format Article
id doaj-art-ce6a7baa17f948fa84cb30a6b9f93a02
institution Kabale University
issn 1095-953X
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj-art-ce6a7baa17f948fa84cb30a6b9f93a022025-02-10T04:34:13ZengElsevierNeurobiology of Disease1095-953X2025-03-01206106833Microglia TRPC1 SUMOylation drives neuroinflammation after stroke by modulating NLRP3 activity via increasing TRPC1 interaction with ARRB2Huinan Zhang0Xinzhe Du1Tian Gao2Xing Wang3Huifeng Zhang4Manyang Yu5Jing Huang6Health Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, China; Department of Neurology, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, ChinaHealth Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, China; Department of Neurology, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, ChinaHealth Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, ChinaHealth Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, ChinaHealth Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, ChinaHealth Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, ChinaHealth Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, China; Department of Neurology, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, China; Corresponding author at: Health Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an, 710038, China.Microglial canonical transient receptor potential channel 1 (TRPC1) has been proposed to influence neuroinflammation after cerebral ischemia and reperfusion injury (CIRI), however, the underlying mechanism remains poorly understood. This study demonstrates that TRPC1 is modified by small ubiquitin-related modifier (SUMO)ylation. Our findings suggest a notable increase in microglial TRPC1 SUMOylation within both the middle cerebral artery occlusion reperfusion (MCAO/R) model and the in vitro oxygen-glucose deprivation/regeneration model. Mice with a loss of TRPC1 SUMOylation in microglia exhibited improved stroke outcomes including reduced behavior deficits, infarct volume, blood brain barrier damage as well as neuronal apoptosis. Mechanistically, SUMOylation of microglial TRPC1 exacerbated neutrophil infiltration into the peri-infarct area. Additionally, SUMOylated TRPC1 activates the Nod-like receptor protein (NLRP) 3 signaling pathway in microglia and stimulates multiple CC-chemokine ligands and C-X-C motif ligand chemokines after MCAO/R. SUMOylated TRPC1 facilitates the interaction between TRPC1 and β-arrestin2 (ARRB2), a negative regulator of NLRP3 inflammasome, which disrupts the NLPR3/ARRB2 complex and stimulates the activation of the NLPR3 signaling pathway. Furthermore, ARRB2 directly binds to the residues 46 to 61 of TRPC1 N terminus, which is enhanced by TRPC1 SUMOylation. Collectively, our findings demonstrate a previously unidentified mechanism by which SUMOylated TRPC1 in microglia regulates leukocyte infiltration after stroke, suggesting that the inhibition of microglial TRPC1 SUMOylation may provide therapeutic benefits for CIRI.http://www.sciencedirect.com/science/article/pii/S096999612500049XARRB2TRPC1SUMOylationNLRP3StrokeMicroglia
spellingShingle Huinan Zhang
Xinzhe Du
Tian Gao
Xing Wang
Huifeng Zhang
Manyang Yu
Jing Huang
Microglia TRPC1 SUMOylation drives neuroinflammation after stroke by modulating NLRP3 activity via increasing TRPC1 interaction with ARRB2
Neurobiology of Disease
ARRB2
TRPC1
SUMOylation
NLRP3
Stroke
Microglia
title Microglia TRPC1 SUMOylation drives neuroinflammation after stroke by modulating NLRP3 activity via increasing TRPC1 interaction with ARRB2
title_full Microglia TRPC1 SUMOylation drives neuroinflammation after stroke by modulating NLRP3 activity via increasing TRPC1 interaction with ARRB2
title_fullStr Microglia TRPC1 SUMOylation drives neuroinflammation after stroke by modulating NLRP3 activity via increasing TRPC1 interaction with ARRB2
title_full_unstemmed Microglia TRPC1 SUMOylation drives neuroinflammation after stroke by modulating NLRP3 activity via increasing TRPC1 interaction with ARRB2
title_short Microglia TRPC1 SUMOylation drives neuroinflammation after stroke by modulating NLRP3 activity via increasing TRPC1 interaction with ARRB2
title_sort microglia trpc1 sumoylation drives neuroinflammation after stroke by modulating nlrp3 activity via increasing trpc1 interaction with arrb2
topic ARRB2
TRPC1
SUMOylation
NLRP3
Stroke
Microglia
url http://www.sciencedirect.com/science/article/pii/S096999612500049X
work_keys_str_mv AT huinanzhang microgliatrpc1sumoylationdrivesneuroinflammationafterstrokebymodulatingnlrp3activityviaincreasingtrpc1interactionwitharrb2
AT xinzhedu microgliatrpc1sumoylationdrivesneuroinflammationafterstrokebymodulatingnlrp3activityviaincreasingtrpc1interactionwitharrb2
AT tiangao microgliatrpc1sumoylationdrivesneuroinflammationafterstrokebymodulatingnlrp3activityviaincreasingtrpc1interactionwitharrb2
AT xingwang microgliatrpc1sumoylationdrivesneuroinflammationafterstrokebymodulatingnlrp3activityviaincreasingtrpc1interactionwitharrb2
AT huifengzhang microgliatrpc1sumoylationdrivesneuroinflammationafterstrokebymodulatingnlrp3activityviaincreasingtrpc1interactionwitharrb2
AT manyangyu microgliatrpc1sumoylationdrivesneuroinflammationafterstrokebymodulatingnlrp3activityviaincreasingtrpc1interactionwitharrb2
AT jinghuang microgliatrpc1sumoylationdrivesneuroinflammationafterstrokebymodulatingnlrp3activityviaincreasingtrpc1interactionwitharrb2